Hjem › Endetarmskreft › Massachusetts › Boston
Kliniske studier for Endetarmskreft i Boston, MA
12 studier for Endetarmskreft søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
- Dana-Farber Cancer Institute, Boston
The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
Rekrutterer
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Dana Farber Cancer Institute, Boston
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekruttererFase 1/2
- Massachusetts General Hospital - Main Campus, Boston
Resilience and Equity in Aging, Cancer, and Health (REACH)
Rekrutterer
- Dana-Farber Cancer Institute, Boston
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Rekrutterer
- Massachusetts General Hospital Cancer Center, Boston
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
Rekrutterer
- Massachusetts General Hospital, Boston
RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
RekruttererFase 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruttererFase 1
- Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Massachusetts General Hospital, Boston
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
RekruttererFase 1/2
- Dana Farber Cancer Institute, Boston
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
Rekrutterer
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Endetarmskreft-studier i andre byer
- New York City, NY17 studier
- Houston, TX11 studier
- St. Louis, MO11 studier
- Columbus, OH10 studier
- Los Angeles, CA10 studier
- Seattle, WA9 studier
- Tampa, FL9 studier
- Nashville, TN9 studier
- Chicago, IL8 studier
- Rochester, MN8 studier
- Philadelphia, PA8 studier
- Aurora, CO8 studier
Andre studier i Boston
- Brystkreft111 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)86 studier
- Kolorektal kreft63 studier
- Metastatisk kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.